When antidepressants haven't worked, Spravato® offers a different path. Physician-supervised, in-office treatment. Medicare and most major insurers cover qualifying patients.
Spravato® (esketamine) is FDA-approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation. Because it's FDA-approved — not off-label — most major insurers and Medicare cover it for qualifying patients.
We handle the verification process for you. Before you commit to anything, we'll check your benefits and tell you exactly what to expect.
Traditional antidepressants work on serotonin. Spravato® works differently — directly on NMDA receptors — which is why it helps patients who haven't responded to other medications.
Spravato® is esketamine — a nasal spray derived from ketamine and approved by the FDA in 2019 specifically for adults with treatment-resistant depression (TRD) or major depressive disorder with acute suicidal ideation (MDD-SI).
Sessions are administered in our Livermore clinic under physician supervision. You'll relax in a private room for approximately two hours while the medication is active. Dr. Parsa monitors you throughout.
Most patients complete an induction phase (twice weekly for 4 weeks), followed by a maintenance schedule (weekly, then monthly). Many report improvement within the first 1-2 sessions.
Call or fill out the form. We verify your coverage and confirm what — if anything — you'll pay. No commitment to move forward.
Dr. Parsa reviews your history, medications, and diagnosis to confirm Spravato® is the right fit. Usually same week.
In-office sessions, fully supervised. You rest in a calm room; we monitor you throughout. Most begin feeling better within 1-4 sessions.
Not sure if you qualify? Call us — the evaluation is free and there's no pressure.
I'm a Family Medicine physician with 15 years across urgent care, emergency medicine, inpatient, and street medicine. That breadth is what led me here — to the intersection of consciousness and healing.
I'm a certified Spravato® provider and have worked extensively with patients who felt hopeless after years of failed treatments. There's almost always a path forward. My job is to find it with you.
"Being with him felt like talking to an old friend I hadn't seen in a long time — someone safe, familiar, and genuinely invested in my well-being. I experienced clarity for the first time in my life."
"The improvement I've seen in mood, clarity, and overall wellbeing has been remarkable. It's clear he genuinely cares about his patients and their recovery."
Insurance verification is free. Consultations are same-week. There's no commitment required to find out if you qualify. Just a conversation with a physician who genuinely wants to help.
Mind Balance Flow · 1985 1st Street, Livermore, CA 94550
We'll call you within 1 business day.
Medical Disclaimer: Spravato® (esketamine) is FDA-approved for treatment-resistant depression (TRD) and major depressive disorder with acute suicidal ideation (MDD-SI). Individual results vary. This page does not constitute medical advice. Consult a qualified healthcare provider before beginning treatment.
Insurance Coverage: Coverage varies by plan and individual eligibility. We verify benefits before treatment begins. Not all patients will qualify for insurance coverage. Out-of-pocket options available.
HIPAA Notice: Do not submit protected health information through this form. To discuss your medical history, call us directly at (925) 438-6627.
·
Privacy Policy
·
Spravato® is a registered trademark of Janssen Pharmaceuticals.